SenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a report released on Saturday morning. The firm issued a sell rating on the stock.

Separately, HC Wainwright reissued a buy rating and set a $3.50 price target on shares of SenesTech in a research note on Tuesday, May 14th.

Read Our Latest Stock Report on SenesTech

SenesTech Stock Performance

SNES stock opened at $0.41 on Friday. The company has a current ratio of 6.91, a quick ratio of 5.69 and a debt-to-equity ratio of 0.03. The business’s fifty day moving average price is $0.64 and its two-hundred day moving average price is $0.78. SenesTech has a fifty-two week low of $0.40 and a fifty-two week high of $11.52.

SenesTech shares are set to reverse split on Thursday, July 25th. The 1-10 reverse split was announced on Tuesday, July 23rd. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, July 24th.

SenesTech (NASDAQ:SNESGet Free Report) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The company had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.43 million. During the same quarter in the previous year, the business posted ($15.85) EPS. As a group, analysts anticipate that SenesTech will post -1.1 EPS for the current year.

Institutional Trading of SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC purchased a new position in shares of SenesTech, Inc. (NASDAQ:SNESFree Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned approximately 1.25% of SenesTech as of its most recent filing with the SEC. Institutional investors and hedge funds own 5.19% of the company’s stock.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Read More

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.